Starsource Multitrade

Starsource Multitrade Equity

The The Equity of Starsource Multitrade (506365.BO) as of Oct 19, 2026 is 12.90 M INR. In the previous year, The Equity was 131.45 M INR — a change of -90.19% (lower).

Equity

12.90 MINR

YoY

-90.19%

Last updated:

In 2026, Starsource Multitrade's equity was 12.90 M INR, a -90.19% increase from the 131.45 M INR equity in the previous year.

The Starsource Multitrade Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
103.30 M INR
Jan 1, 2020
107.45 M INR
Jan 1, 2021
109.95 M INR
Jan 1, 2022
115.55 M INR
Jan 1, 2023
116.02 M INR
Jan 1, 2024
128.02 M INR
Jan 1, 2025
131.45 M INR
Jan 1, 2026
12.90 M INR
The Starsource Multitrade Equity history
YEAREquityYoY
12.90 MINR-90.19%
131.45 MINR+2.67%
128.02 MINR+10.35%
116.02 MINR+0.41%
115.55 MINR+5.09%
109.95 MINR+2.33%
107.45 MINR+4.02%
103.30 MINR+2.04%
101.23 MINR+1.00%
100.23 MINR+172.88%
36.73 MINR-28.29%
51.22 MINR+5.59%
48.50 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd, identified by the ticker symbol 506365.BO and ISIN INE320M01019, is a corporate entity registered in India with its headquarters located in Mumbai, Maharashtra. The company was originally established through an initial public offering on January 2, 1995. While the specific sector and industry classifications are currently listed as not applicable, the company's operational history and strategic direction are closely tied to its former identity as Chemo Pharma Laboratories Ltd. This previous incarnation operated within the pharmaceutical industry, focusing on the development and distribution of healthcare products. However, the corporate landscape has shifted significantly, and the entity is no longer engaged in its original pharmaceutical activities. According to available information, the firm currently has no active operations within its traditional business lines. Instead, the organization is in a transitional phase, actively exploring new business opportunities to redefine its market presence. The strategic intent of the current management is to pivot away from pharmaceuticals and acquire businesses in the power and chemicals sectors. This move represents a substantial change in the company's core focus, aiming to diversify its portfolio and enter entirely different industrial segments. The company's official website, https://www.thechemopharmalaboratoriesltd.com/, reflects its historical branding, although the operational reality has evolved. Investors and stakeholders monitoring the company should note that the absence of current operations means that recent financial performance may not reflect traditional revenue streams associated with pharmaceutical manufacturing or sales. The focus is currently on strategic acquisitions and business development rather than organic growth from existing products. The transition from a pharmaceutical manufacturer to a holding or investment vehicle targeting power and chemical assets suggests a long-term restructuring plan. Until new acquisitions are finalized and integrated, the company remains in a state of exploration and preparation. The headquarters in Mumbai serves as the administrative center for these strategic discussions and future operational planning. The lack of a defined sector classification further underscores the company's current status as an entity in flux, waiting for new business units to be acquired and operationalized. This profile highlights the significant shift from its historical roots in healthcare to its current ambitions in energy and industrial chemicals, marking a distinct chapter in the company's corporate evolution. Starsource Multitrade is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Starsource Multitrade's Equity

Starsource Multitrade's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Starsource Multitrade's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Starsource Multitrade's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Starsource Multitrade's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Starsource Multitrade’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Starsource Multitrade stock

The Equity of Starsource Multitrade is 12.90 M INR in 2026.

The Equity of Starsource Multitrade changed from 131.45 M INR to 12.90 M INR, representing a -90.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

The Equity's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Starsource Multitrade historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Starsource Multitrade

All Key Metrics — Starsource Multitrade